pharmaphorum July 22, 2024
Phil Taylor

Scientists in the US have developed a new universal form of influenza vaccine that they say could protect against all strains of the virus – and do away with the annual scramble to match shots to circulating flu strains.

The team led by researchers at Oregon Health & Science University (OHSU) think their ‘one and done’ model – which uses a cytomegalovirus (CMV) vector – could confer lifetime immunity against the evolving virus.

While still in the animal testing stage, initial results published in Nature Communications have been promising against H5N1, a bird flu strain that is a frontrunner to cause a new pandemic.

In the past few years, a highly pathogenic strain of H5N1 has emerged that can jump...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID, Trends
Journalists Give Rundown on Bird Flu Risks, HIV Rates, and the Fate of Shuttered Hospitals
Advancing a Public Health Services & Systems Research Agenda in 2024
Joseph Allen: The Pivotal Importance of Air Quality, Ventilation and Exposures (Such as "Forever Chemicals") For Our Health
Q&A: What you need to know about the latest mpox outbreak
Boom, Now Bust: Budget Cuts and Layoffs Take Hold in Public Health

Share This Article